个人简历

1、1985.09~1989.07 陕西师范大学，化学系，学士
2、1989.07~1996.08 西安飞机工业公司，工程师
3、1996.09~2005.08 江南大学化工学院，讲师，副教授，硕士
4、2005.09~至今 浙江理工大学，副教授、教授

研究领域

1. 肿瘤非编码RNA的表达和机理研究
2. 药用天然化合物筛选及作用机制

近期论文

1. T Ji, Z Zheng, F Wang, L Xu, L Li, Q Cheng, J Guo, X Ding*（2014）, Differential microRNA expression by Solexa sequencing in the sera of the ovarian cancer patients. Asian Pacific journal of cancer prevention，15: 1739-1743
2. Ding X*, Zhu L, Ji T, Zhang X, Wang F, Gan S, Zhao M, Yang H（2014）. Long Intergenic Non-Coding RNAs (LincRNAs) Identified by RNA-Seq in Breast Cancer，PLOS ONE,9(8):1-10
3. S Zhang,C Zhu，L Zhu, HLiu, S Liu, N Zhao,J Wu, X Huang, Y Zhang, J Jin, T Ji, X Ding, Oncogenicity of the Transcription Factor Sox8 in Hepatocellular Carcinoma, Med Oncol (2014) 31(918): 3-6
4. F Yi，F Yang，X Liu，H Chen，T Ji，L Jiang，X Wang, Z Yang，L Zhang，X Ding*, Z Liang* and Q Du*(2013)，RNA-seq identified a super-long intergenic transcript functioning in adipogenesis, , RNA Biology ,10:6, 1–12
5. Yang F, Yi F, Zheng Z, Ling Z, Ding J, Guo J, Mao W, Wang X, Ding X*，Liang Z, and Du Q (2012), Characterization of a carcinogenesis-associated long non-coding RNA, RNA Biology, 9(1): 110 – 116
6.Ding X*, Ding J, Ning J, Yi F, Zhao D, Zheng J, Liang Z, Hu Z, Du Q（2012）Circulating microRNA as a potential biomarker for liver injury, Molecular Medicine Reports , 5: 1428-1432
7. Li Y, Jiang Z, Xu L, Guo J and Ding X* (2011) Stability Analysis of Liver Cancer Related MicroRNAs in Serum. Acta Biochimica et Biophysica Sinica，43(1) :69-78.
8.Huang H, Wei Z, Huang Y, Zhao D. Zheng L, Cai, T, Wu N，Wang W, Ding X， Du,Q , Li Z, Liang Z (2011) An efficient and high-throughput electroporation microchip applicable for siRNA delivery. Lab on a Chip, 11(1):163-72
9. Wang F, Zheng Z, Guo J and Ding X* (2010) Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecologic Oncology, 119(3): 586-593
10. Huang H, Qiao R, Zhao D, Zhang T, Li Y, Yi F, Lai F, Hong J, Ding X, Yang Z, Zhang L, Du Q, Liang Z* (2009) Profiling of mismatch discrimination in RNAi enabled rational design of allele-specific siRNAs. Nucleic Acids Res. 37(22): 7560-7569
11. X Meng, Y Li,H Tang,W Mao, H Yang,X Wang, X Ding*, Sh Xie, Drug response to HER2 gatekeeper T798M mutation in HER2-positive breast cancer, Amino Acids, 2016,48(2), 487-497
12. J Huang, A Zhang, T Ho, Z Zhang, N Zhou, X Ding, X Zhang, Min Xu， and Y Mo,*，Linc-RoR promotes c-Myc expression through hnRNP，I and AUF1，Nucleic Acids Research, 2016 , 44(7):3059-69
13. H Liu, J Li, P Koirala, X Ding, B Chen, Y Wang, Z Wang, C Wang, X, Y Mo Long non-coding RNAs as prognostic markers in human breast cancer，oncotarget, 2016,03